• Product NameChromocarbe
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityChromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections. Peroral treatment of rats with Chromocarb significantly reduces the degradation of the vascular wall by intravenous collagenase. Chromocarb treatment induces a lesser permeability increase of the BBB, a shorter recovery time, lower hydroxyproline levels in the cerebrospinal fluid and a lesser decrease of the collagen content of the brain capillary basal lamina
• Target NameOthers
• CAS No. 4940-39-0
• Calculated MW 190.15
• Formulation C10H6O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:OC(=O)C1=CC(=O)C2=CC=CC=C2O1
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:260C
  Solubility:DMSO: 38 mg/mL (199.84 mM)
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Godeau G, et al. Clin Physiol Biochem, 1987, 5(1), 15-26.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting